Life Technologies buys Advanced Microscopy Group; EU awards $7.6M for preeclampsia Dx consortium;

 @FierceMedDev: Some regulatory decisions on devices and drugs may face delays. Blame Hurricane Sandy. More | Follow @FierceMedDev

 @MarkHFierce: More woes for Abiomed. Shareholders will now investigate the company's marketing and labeling of its Impella 2.5. More | Follow @MarkHFierce

 @DamianFierce: The Indian clinical trial industry will continue to explode, but only if it cleans up its act, TOI says. More | Follow @DamianFierce

> X-spine gained FDA clearance for two of its spinal implant systems. Item

> Drexel University researchers have come up with a near infrared device designed to help locate bedsores in patients before they appear on the skin. Story

> The European Union will give out more than $7.6 million in research funding to a consortium working to develop a predictive diagnostic test for preeclampsia. Release

> The FDA is blaming the massive storm Sandy for likely delays in the coming weeks for medical device, biosimilar and prescription drug approvals. Story

> Scientists at Belgium's Vrije Universiteit Brussel have developed a prosthetic foot that mimics the way a human ankle springs. Item

> Life Technologies ($LIFE) has snatched up Advanced Microscopy Group, a developer of imaging systems for research microscopy. Release

> Brigham Young University scientists have come up with a low-cost device that will allow for inexpensive testing of diseases. Story

Biotech News

 @FierceBiotech: Merck finds pharma research results with online competition. More | Follow @FierceBiotech

 @JohnCFierce: BioMarin shares pop on strong pivotal data for rare disease drug. More | Follow @JohnCFierce

 @RyanMFierce: Winners named in Merck's online competition involving pharma research, Kaggle blog. More | Follow @RyanMFierce

> Ex-Pfizer crew snags $27M financing for U.K. drugs startup. News

> Experts rip chelation heart study despite a hint of efficacy. Article

Pharma News

@FiercePharma: FDA backs Boehringer Ingelheim's Pradaxa on safety. Big caution, though, in bold type: Use as directed. More | Follow @FiercePharma

> Sanofi brass considered pulling home base out of France. Article

> Drugmakers offer Greece option to end bad debt spiral. News

> India strips patent from Roche's hep C drug Pegasys. Story

Biotech IT News

> Roche seeks advances in cloud computing for cancer drug research. News

> Sanofi deal bolsters Medidata in record quarter for revenue. Article

> Titan slays Jaguar in computing comparison, open to R&D comers. Report

>Merck finds pharma research results with online competition. Story

CRO News

> Quintiles chief: CROs need to jump on sequencing bandwagon. Item

> GE pours $23M into Biocon's CRO as it plots public offering. Story

> Icon soars in Q3, plots Nasdaq jump. Report

> Cyprotex snags deal with Pfizer for toxicology. More

> Charles River pays $27M for majority of Chinese company. News

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.